Accelerating compliance
and approvals with unmatched regulatory insight and experience.

Contact Us Today
The Lachman Difference

The most efficient services.
The most qualified professionals.

Since 1978, Lachman Consultants’ multidisciplinary team of highly experienced FDA consultants and industry experts has offered compliance, regulatory affairs, and science & technology services to clients around the world.

Learn More About Us

Stay in the know

Sign up today for the Lachman Consultants blog.

Get the latest news on industry compliance, regulatory affairs, technical services, and a whole lot more.

    AREAS SERVED BY LACHMAN CONSULTANTS

    ADVANCE. CONFIDENTLY.

    As long-standing leaders in technical and regulatory consulting services, Lachman Consultants provides both experience and excellence through an unmatched team of respected industry professionals and SMEs.

    Mock FDA Audits

    Are you fully prepared for an inspection at your facility?

    Our team of experienced ex-FDA investigators offer comprehensive Mock FDA Audit services to help you prepare for an actual FDA inspection. Our team of experts will conduct a thorough inspection of your facility, review your documentation, and provide you with valuable feedback on areas that need improvement to ensure compliance with FDA regulations – both remotely and on-site.

    Learn More About Mock FDA Audits

    OnCall Image

    Recent Posts

    The Lachman Consultants Blog

    The latest on industry compliance, regulatory affairs, technical services, and a whole lot more.

    Lachman Consultants at PDA Singapore 2026: Expert Perspectives on WFI, Cleanrooms, and Annex 1 Applicability

    Two of our Senior Directors, Andy Hopkins and Bob Wittorf, will be spe...
    Read More

    What’s All the Hubbub, Bub? GSK Withdrawals Leucovorin Calcium–Again!

    A few months before the end of 2025, the FDA requested that Glaxo Smit...
    Read More
    Dapagloflozin Approvals

    Dapagloflozin Approvals

    On Tuesday, April 7th, the FDA announced that the Office of Generic D...
    Read More

    Artificial Intelligence: From Exploration to Operationalization—Parenteral Drug Association Week 2026 Reflections

    There’s always a certain energy at PDA Week – the kind that comes ...
    Read More
    How Does This Stuff Continue to Happen?

    How Does This Stuff Continue to Happen?

    Today, the FDA issued yet another health warning regarding an unapprov...
    Read More

    Unofficial March 2026 ANDA Approval Actions Keep on Pace

    The FDA has posted a total of 82 approval actions in March to date on ...
    Read More
    ADVANCE CONFIDENTLY
    Contact Us Today